BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.561
-0.024 (-4.12%)
At close: Dec 20, 2024, 4:00 PM
0.580
+0.019 (3.39%)
After-hours: Dec 20, 2024, 7:28 PM EST
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$1,037,199
Market Cap
25.53M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 118 |
| Curis | 49 |
| Calidi Biotherapeutics | 41 |
| LAVA Therapeutics | 37 |
| Femasys | 34 |
| Cognition Therapeutics | 28 |
| NeuroSense Therapeutics | 18 |
| Lipocine | 17 |
BCTX News
- 4 days ago - BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures - GlobeNewsWire
- 4 days ago - BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures - GlobeNewsWire
- 8 days ago - BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering - GlobeNewsWire
- 8 days ago - BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer - GlobeNewsWire
- 9 days ago - BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering - GlobeNewsWire
- 10 days ago - BriaCell Therapeutics Announces Proposed Public Offering - GlobeNewsWire
- 10 days ago - BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS® - GlobeNewsWire
- 19 days ago - BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer - GlobeNewsWire